PlainIndex

ETF comparison

BBAX vs EFG

Both International Developed.

JPMorgan BetaBuilders Developed Asia Pacific ex-Japan ETF · iShares MSCI EAFE Growth ETF

Holdings overlap

0.0 %

0 positions appear in both funds. Buying equal dollars of BBAX and EFG would leave roughly 0.0% of each dollar exposed to the same underlying securities.

BBAX only 0.0% Shared 0.0% EFG only 0.0%
In BBAX only
0 positions
Shared
0 positions
In EFG only
0 positions

Holdings data for BBAX covers 0.0% of fund weight. The remainder lacks matchable identifiers in the N-PORT filing.

Holdings data for EFG covers 0.0% of fund weight. The remainder lacks matchable identifiers in the N-PORT filing.

Side by side

BBAX

JPMorgan BetaBuilders Developed Asia Pacific ex-Japan ETF

JPMorgan · International Developed

81 composite / 100
Expense ratio
0.19%
Net assets
$6.39B
TTM yield
3.57%
Top-10 conc.
EFG

iShares MSCI EAFE Growth ETF

iShares · International Developed

78 composite / 100
Expense ratio
0.34%
Net assets
$15.18B
TTM yield
2.41%
Top-10 conc.

Sub-score comparison

81
Cost
66
70
Tax efficiency
74
92
Liquidity
100
N/A
Concentration
N/A
Tracking quality
BBAX sub-score EFG

Tracking-quality sub-score is not yet computed for any fund — see methodology for which inputs are live.

Cost difference

BBAX is 15 bps cheaper than EFG. On a $100,000 position that's about $150/yr more in fees for EFG.

Fee figure is the annual expense charged on $100,000. It compounds over time — we publish a fuller cost-projection calculator on the methodology page.

Top shared holdings

0 shared in total

No shared holdings between these funds.

Only in BBAX

0 total

Every BBAX position is also held by EFG.

Only in EFG

0 total

Every EFG position is also held by BBAX.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.